Pharsight Corporation Announces Fiscal Second Quarter 2007 Earnings Release Date And Conference Call

MOUNTAIN VIEW, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software and strategic services for optimizing clinical drug development, today announced that it will release financial results for the fiscal second quarter of 2007, which ended September 30, 2006, after the market closes on Thursday, October 26, 2006. The Company will host a conference call and webcast on Friday, October 27, 2006 at 10:00 a.m. Pacific Time to discuss the Company’s fiscal second quarter results, outlook for the remainder of fiscal 2007, and current corporate developments. The dial-in number for the conference call is 800-240-4186 for domestic participants and 303-262-2137 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will remain available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, using passcode 11073851#. To access the live webcast of the call, go to Pharsight’s website at www.pharsight.com . An archived webcast will also be available at www.pharsight.com .

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company’s goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight’s approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com .

Registered Trademarks and Trademarks

Pharsight(R) is a registered trademark of Pharsight Corporation.

Pharsight Corporation

CONTACT: investors, Douglas Sherk, or Jennifer Beugelmans,+1-415-896-6820, or media, Jen Saunders, +1-646-277-8720, all of EVC Group,for Pharsight Corporation

MORE ON THIS TOPIC